| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.57B | — |
| Operating expense | — | — |
| Net income | 585.26M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CONCORDBIO.NS returned -8.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +15.7% |
| 1 year | -8.8% |
| All-time high | ₹2,210.75 (Dec 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in CONCORDBIO.NS would be worth today ›Yes. Concord Biotech Limited paid 2 dividends over the past 12 months. The most recent was ₹7.55 per share on Jul 24, 2026. The dividend yield is 0.49%.
Concord Biotech Limited is part of the Healthcare sector.
Concord Biotech Limited has a market cap of 161.95B INR, based on the latest quote.
